Tag: Health Care

Displaying 521 - 540 of 840 results.

The Federal Trade Commission today announced a consent order settling charges that an independent practice association, representing two orthopaedic groups in Cincinnati, Ohio, violated antitrust laws by jointly negotiating contracts regarding the rates its physician members would charge health...
Commission authorization of the staff to file amended complaint: The Commission has authorized the staff to file an amended complaint in the case currently pending against CHK Trading Corp., et al. (CHK). Announced as part of the FTC’s “Operation Big Fat Lie” law enforcement sweep targeting...
The Federal Trade Commission today filed a petition with the Court of Appeals for the Eleventh Circuit, in Atlanta, Georgia, requesting that the Court vacate its March 8, 2005 decision in the matter of FTC v. Schering-Plough Corporation, No. 04-10688, and re-hear the case en banc.
Commission approval of petition to reopen and modify final order: The Commission has approved a petition from Aventis S.A. (Aventis), the successor company to Hoechst AG and Rhone-Poulenc S.A. (RP) (the respondents), to reopen and modify a final consent order regarding the 1999 merger of the two...
Commission response to Food and Drug Administration citizen petition: The Commission has authorized the submission of a response to the U.S. Food and Drug Administration (FDA) regarding a citizen petition filed with the FDA by IVAX Pharmaceuticals, Inc. (IVAX) on January 5, 2005. The petition...
Under the terms of a consent order with the Federal Trade Commission announced today, a Chicago-area physicians’ group has agreed to stop collectively bargaining on behalf of its members, as such joint negotiations allegedly led to reduced competition and higher prices paid by health plans and...
In a letter submitted today at the request of Virginia State Delegate Harry Purkey, staff of the Federal Trade Commission’s Office of Policy Planning, Bureau of Competition, and Bureau of Economics commented on three bills that the Virginia Assembly considered during the legislative session: HB...
In a comment submitted to North Dakota State Senator Richard L. Brown at his request, staff of the Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition stated that House Bill (HB) 1332, which currently is pending in the legislature, might have the...
The order prohibits Preferred Health Services from orchestrating collective agreements and other terms for physician services when negotiating with health insurance plans and other third party payers. According to the complaint these agreements among the physician-hospital...
Under a consent order announced today by the Federal Trade Commission, Preferred Health Services, Inc. (Preferred Health), a physician-hospital organization consisting of more than 100 doctors and the Oconee Memorial Hospital in northwestern South Carolina, has been barred from collectively...
The Federal Trade Commission has released a study on the strength of competition in the sale of prescription contact lenses. Congress required the study under the Fairness to Contact Lens Consumers Act (FCLCA), which was enacted to promote competition in the contact lens market by enhancing...
Commission authorization of the staff to file amicus brief: The Commission has authorized the staff to file a brief as amicus curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc., Case No. 04-1186 (Fed. Cir.) in support of Teva’s petition for rehearing or rehearing en banc. The case, which was...
In this amicus brief in support of Teva’s combined petition for rehearing and rehearing en banc, the Commission argues that the court erred in affirming the district court’s dismissal of Teva’s complaint in this Hatch-Waxman Act case. The brief argues that the court applied the wrong...
Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc. The Commission vote approving the final consent order was 4-0-1, with Commissioner Pamela Jones...
The Commission has approved a petition for proposed divestiture received from General Electric Company (GE) and related to the FTC decision and order regarding GE’s acquisition of InVision Technologies (InVision). Under the terms of the order, within six months of the execution date the consent...
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an...
The Federal Trade Commission today announced that it will conditionally allow Genzyme Corporation’s (Genzyme) proposed $1 billion acquisition of ILEX Oncology, Inc. (Ilex), provided the companies divest overlapping assets in the U.S. market for solid organ transplant (SOT) acute therapy drugs....
In an initial decision filed on November 8, 2004, and announced today, Administrative Law Judge (ALJ) D. Michael Chappell upheld a Federal Trade Commission complaint filed last year against a physicians’ group practicing in Fort Worth, Texas. In the complaint, the FTC alleged the physicians’ group...

Pages